Sanofi-Aventis Czech Republic - Total Debt Growth

Created with Highcharts 6.0.4%2005200620072008200920102011201220132014201520162017-75-50-250255075100125

Sanofi-Aventis CR`s Total Debt Growth reached 32.2 % in 2017. This is 28.3 % less than in the previous year.

$1.99

Buy Total Debt Growth data for Sanofi-Aventis Czech Republic.

$19.99

Buy all data for Sanofi-Aventis Czech Republic.

from $199/month

Buy annual subscriptions for all our products.

 
CompanyUnit
Amgen Czech Republic %
Bayer Czech Republic %
GlaxoSmithKline Czech Republic %
Merck Czech Republic %
Novartis Czech Republic %
Pfizer Czech Republic %
Roche Czech Republic %
Sanofi-Aventis Czech Republic %
Walmark %
2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017
... ... ... ... ... ... ... ... ... ... ... ... ... 137,021 80.5   ...
... ... ... ... ... ... ... ...   ... ... ... ... -68.3 428    
... ... ...               74.0 -33.7 33.3 -100 ... ... ...
... ...                 24.2 -12.8 18.1 -85.0 -100 ... ...
        ...           24.4 -73.0 -100 ... -100 ...  
... ... ... ...       ...   ... ... -100 ... ... ... ... ...
... ... ...           ...   -100 ... 88.9 89.9 21.8   ...
... ... ... ...             -7.86 21.0 -37.4 -46.6 -14.2    
... ... ...               -36.1 327 -1.50 7.02 61.0